| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥502.4B | ¥470.7B | +6.7% |
| Operating Income | ¥34.3B | ¥33.3B | +3.2% |
| Ordinary Income | ¥34.1B | ¥35.7B | -4.6% |
| Net Income | ¥20.4B | ¥15.3B | +33.7% |
| ROE | 5.0% | 4.0% | - |
FY2025 consolidated results: Revenue of 50.2 billion yen increased 6.7% YoY from 47.1 billion yen, operating income of 3.4 billion yen rose 3.2% YoY from 3.3 billion yen, ordinary income of 3.4 billion yen decreased 4.6% YoY from 3.6 billion yen, and net income of 2.0 billion yen increased 33.7% YoY from 1.5 billion yen. The revenue growth was driven primarily by the Fastener segment expansion of 10.2% YoY to 37.1 billion yen, while profit growth lagged behind revenue growth due to cost increases. The gap between operating income growth of 3.2% and net income growth of 33.7% reflects significant YoY improvement in tax burden, as prior year net income was suppressed by higher tax expenses. Operating margin stood at 6.8%, declining 0.2 percentage points from 7.1% YoY.
Revenue increased 3.2 billion yen or 6.7% YoY to 50.2 billion yen, driven by growth across three of four reporting segments. The Fastener segment generated 37.1 billion yen in external sales, up 10.2% YoY, representing 73.9% of total revenue and serving as the primary growth engine. The Control System segment recorded 6.7 billion yen in sales, declining 0.4% YoY from 6.7 billion yen, while the Machinery segment decreased 5.5% YoY to 6.3 billion yen from 6.6 billion yen. The Medical segment, while expanding significantly from 0.02 billion yen to 0.15 billion yen, remained immaterial at 0.3% of total revenue. Revenue growth was concentrated in the core Fastener business, with the two industrial equipment segments experiencing modest contraction.
Operating income advanced 0.1 billion yen or 3.2% YoY to 3.4 billion yen. The slower profit growth relative to revenue expansion resulted in operating margin compression to 6.8% from 7.1% YoY. Segment profit analysis shows the Fastener segment contributed 2.3 billion yen in operating profit, up 38.8% YoY, while the Machinery segment decreased 33.4% YoY to 0.8 billion yen and the Control System segment declined 24.7% YoY to 0.5 billion yen. The Medical segment posted an operating loss of 0.1 billion yen, improving from a 0.12 billion yen loss in the prior year. Cost of sales increased to 38.1 billion yen from 35.5 billion yen, representing 75.9% of revenue. Selling, general and administrative expenses rose to 8.6 billion yen, though the ratio to revenue improved slightly. Depreciation increased 4.1% YoY to 1.5 billion yen, and goodwill amortization rose to 0.1 billion yen from 0.06 billion yen, reflecting recent M&A activity.
Ordinary income declined 1.6 billion yen or 4.6% YoY to 3.4 billion yen despite operating income growth, indicating net non-operating expenses of 0.2 billion yen compared to net non-operating income of 0.4 billion yen in the prior year. This 0.6 billion yen deterioration in the non-operating account represents a 16.8% drag relative to operating income. Net income increased 5.1 billion yen or 33.7% YoY to 2.0 billion yen, substantially outpacing ordinary income decline. This divergence stems from a significant reduction in tax burden, with income tax expenses decreasing to 1.4 billion yen from 2.0 billion yen YoY, resulting in an effective tax rate of 39.1% compared to 56.9% in the prior year. The prior year's elevated tax rate appears to reflect one-time tax adjustments or deferred tax asset impairment. The net income expansion should thus be viewed as partially attributable to tax normalization rather than sustained operational improvement.
This represents a revenue up, profit up pattern, though with important qualifications: while both revenue and operating income advanced, the rate of profit growth lagged revenue growth at the operating level, and ordinary income actually declined. The strong net income performance was largely tax-driven rather than reflecting underlying earnings power expansion.
The Fastener segment serves as the core business, representing 73.9% of total revenue and 66.2% of total segment operating profit. Segment revenue of 37.1 billion yen increased 10.2% YoY, with operating income of 2.3 billion yen advancing 38.8% YoY, yielding an operating margin of 6.1% compared to 4.9% in the prior year. This 1.2 percentage point margin expansion reflects improved operational leverage or favorable product mix. The Machinery segment generated 6.3 billion yen in revenue, down 5.5% YoY, with operating income of 0.8 billion yen declining 33.4% YoY, resulting in margin compression to 12.1% from 17.2% YoY. The Control System segment recorded 6.7 billion yen in revenue, declining 0.4% YoY, with operating income of 0.5 billion yen falling 24.7% YoY and margin contracting to 7.5% from 9.9% YoY. The Medical segment posted 0.15 billion yen in revenue with a 0.1 billion yen operating loss, representing a negative 71.0% margin. Material margin dispersion exists across segments, with Machinery maintaining the highest profitability at 12.1% despite recent deterioration, while Medical remains in development stage with substantial losses. The concentration of both revenue and profit improvement in Fastener, coupled with deterioration in the industrial equipment segments, indicates sector-specific demand divergence and raises questions about sustainability of consolidated profit growth if Fastener momentum moderates.
[Profitability] ROE of 5.2% represents a decrease from the prior year level, falling below the 5-year average, while ROA of 3.7% similarly declined from 2.9% YoY as asset base expanded faster than profit generation. Operating margin of 6.8% contracted 0.2 percentage points from 7.1% YoY, and net profit margin of 4.1% improved 0.8 percentage points from 3.3% YoY, though this improvement was driven by tax rate normalization rather than operational efficiency gains. Gross profit margin of 24.1% declined marginally from 24.6% YoY as cost of sales ratio increased. [Cash Quality] Cash and deposits of 17.7 billion yen declined 4.9 billion yen YoY, with short-term debt of 1.7 billion yen covered 10.3 times by cash, indicating strong liquidity coverage. Operating cash flow of 2.9 billion yen represented 1.4 times net income, confirming cash-backed earnings quality, though the ratio declined from 1.7 times in the prior year. [Investment Efficiency] Total asset turnover of 0.87 declined from 0.85 YoY as assets grew 3.7% to 57.7 billion yen while revenue advanced 6.7%, indicating deteriorating asset efficiency. Inventory turnover deteriorated with days inventory outstanding extending to 112 days from 97 days YoY, representing a significant working capital efficiency decline. Days sales outstanding of 90 days increased from 84 days YoY, while days payables outstanding of 67 days decreased from 77 days YoY, combining to extend the cash conversion cycle to 135 days from 104 days YoY. [Financial Health] Equity ratio of 71.1% improved from 69.4% YoY as equity increased to 41.0 billion yen from 38.6 billion yen, reflecting both retained earnings accumulation and limited leverage increase. Current ratio of 303.0% declined from 322.8% YoY but remains highly conservative, and quick ratio of 261.6% similarly decreased from 284.7% YoY while maintaining ample short-term liquidity. Debt-to-equity ratio of 0.07 increased marginally from 0.04 YoY as interest-bearing debt rose to 2.7 billion yen from 1.6 billion yen, though absolute leverage remains minimal.
Operating cash flow of 2.9 billion yen represents 1.4 times net income, confirming earnings are supported by cash generation, though this conversion ratio declined from 1.7 times in the prior year. The deterioration in cash conversion reflects working capital absorption, particularly inventory buildup and receivables extension. Investing cash flow of negative 2.7 billion yen was driven primarily by capital expenditures of 1.7 billion yen, representing 119.0% of depreciation and indicating growth investment above replacement levels. Additional investing outflows include subsidiary acquisitions and investment security purchases, with goodwill increasing 0.1 billion yen and intangible assets rising 0.2 billion yen YoY, suggesting M&A activity absorbed approximately 0.3 to 0.5 billion yen. Financing cash flow data indicates dividend payments absorbed approximately 0.8 billion yen based on disclosed dividend per share and outstanding shares, while borrowings increased net 1.1 billion yen as short-term borrowings rose 0.4 billion yen and long-term borrowings advanced 0.7 billion yen. Free cash flow of 0.2 billion yen, calculated as operating cash flow minus investing cash flow, declined sharply from 1.6 billion yen in the prior year, indicating limited financial flexibility after satisfying investment requirements. Cash and deposits decreased 4.9 billion yen to 17.7 billion yen, with the decline attributable to the combination of modest free cash flow generation and debt increase being insufficient to offset total cash uses including dividends and working capital absorption. The working capital deterioration, evidenced by 31-day extension of the cash conversion cycle, represents the primary constraint on cash generation and warrants management focus on inventory optimization and receivables collection.
Ordinary income of 3.4 billion yen compared to operating income of 3.4 billion yen indicates net non-operating expense of approximately 0.2 billion yen, a deterioration from net non-operating income of 0.4 billion yen in the prior year. Non-operating income of 0.7 billion yen comprises primarily foreign exchange gains of 0.07 billion yen and dividend and interest income, while non-operating expenses of 0.9 billion yen include foreign exchange losses of 0.07 billion yen and interest expenses. The net non-operating account represents negative 0.6% of revenue, a modest impact, with the YoY deterioration attributable to reduced financial income or increased financial costs rather than exceptional items. Net income of 2.0 billion yen exceeded ordinary income by negative 1.4 billion yen due to income tax expense of 1.4 billion yen, representing an effective tax rate of 39.1% compared to 56.9% in the prior year. The significant tax rate decline from an abnormally high prior year level suggests the prior year included deferred tax asset adjustments or other one-time tax charges, with current year tax returning to normalized levels. Extraordinary items were immaterial based on the proximity of pretax income to ordinary income. Operating cash flow of 2.9 billion yen exceeded net income of 2.0 billion yen by 1.4 times, indicating healthy earnings quality with profit supported by cash generation. However, the cash conversion ratio declined from 1.7 times YoY due to working capital absorption of approximately 1.0 billion yen, primarily from inventory buildup. No significant accruals warnings emerged, though the working capital deterioration bears monitoring for sustained trends. The earnings composition reflects primarily recurring operational profits with minimal non-operating or extraordinary distortions, and the strong net income growth should be interpreted as tax normalization rather than sustained earnings power expansion given the ordinary income decline.
Full-year guidance projects revenue of 52.0 billion yen, operating income of 3.8 billion yen, ordinary income of 3.8 billion yen, and net income of 2.3 billion yen. Against these targets, actual FY2025 results show revenue achievement of 96.6%, operating income of 90.3%, ordinary income of 89.7%, and net income of 88.7%. The company has not disclosed whether these figures represent completed full-year results or interim progress, though the segment notes reference the period ending December 31, 2025, suggesting these are full-year actuals. If these represent full-year results falling short of initial guidance, the shortfalls of 3.4% in revenue and approximately 10% in profits indicate softer-than-expected performance in the latter portion of the fiscal year, with profit shortfalls exceeding revenue miss due to margin pressure. The forecasted revenue growth of 3.5% YoY and operating income growth of 10.7% YoY reflect expectations for modest top-line expansion with improved operational leverage. The projected operating margin improvement to 7.3% from 6.8% implies anticipated cost efficiency gains or favorable business mix. Net income growth forecast of 12.7% YoY assumes stable tax rates and non-operating results. The guidance assumes continued Fastener segment strength, recovery in Machinery and Control System segments, and Medical segment loss narrowing. Foreign exchange assumptions and raw material cost trends would materially impact forecast achievement but are not quantified in available data.
Annual dividend of 12.0 yen per share compares to 10.0 yen in the prior year, representing a 20.0% YoY increase. Based on net income of 2.0 billion yen and approximately 362 million shares outstanding (inferred from equity and per-share data), total dividends approximate 4.3 billion yen, though this calculation likely contains discrepancies as it exceeds net income. Using the disclosed payout ratio calculation methodology, the dividend payout ratio of 32.0% based on forecast guidance (12.0 yen dividend against 63.4 yen forecast EPS) indicates a conservative and sustainable payout level. Against actual net income attributable to owners of parent, the payout ratio would be approximately 36% assuming dividends of 0.8 billion yen, well within sustainable ranges and supported by operating cash flow of 2.9 billion yen. No share buyback activity is disclosed in the available data. The total shareholder return ratio equals the dividend payout ratio of approximately 32% to 36%, indicating a conservative capital allocation approach with substantial retained earnings for internal investment. The dividend increase of 20% YoY signals management confidence in earnings sustainability and shareholder return commitment, though the modest payout ratio preserves financial flexibility for ongoing capital investment and M&A activity evidenced by the 1.7 billion yen capex and subsidiary acquisitions.
Segment concentration risk: The Fastener segment represents 73.9% of revenue and 66.2% of operating profit, with FY2025 growth entirely dependent on this segment as both Machinery and Control System contracted. A demand slowdown in Fastener end-markets, whether from automotive, electronics, or other industrial sectors, would materially impact consolidated results. The 10.2% YoY Fastener revenue growth may reflect cyclical peaks rather than sustainable trends, and profitability concentration amplifies vulnerability to sector-specific headwinds.
Working capital deterioration: Days inventory outstanding extended from 97 days to 112 days YoY, days sales outstanding increased from 84 days to 90 days, and days payables outstanding contracted from 77 days to 67 days, combining to expand the cash conversion cycle by 31 days to 135 days. This 29.8% deterioration in working capital efficiency absorbed approximately 1.0 billion yen of operating cash flow, constraining free cash flow to just 0.2 billion yen. Sustained working capital inefficiency would necessitate external financing for growth investment or dividend maintenance, particularly concerning given increasing debt levels and modest profit margins. Inventory buildup may reflect demand forecast misalignment, supply chain precautionary holdings, or product mix shifts toward longer-cycle items, each carrying distinct implications for future margin and cash generation.
Investment execution and integration risk: Capital expenditures of 1.7 billion yen represent 119% of depreciation, goodwill increased 37.6% YoY to 0.4 billion yen, and intangible assets rose 25.3% YoY to 1.1 billion yen, collectively indicating substantial growth investment and M&A activity. The rapid asset base expansion without commensurate near-term profit improvement resulted in ROA declining to 3.7% and asset turnover deteriorating to 0.87 times. If invested capital fails to generate projected returns, whether from market conditions, integration challenges, or strategic misalignment, the company faces impairment risks on goodwill and intangible assets, and sustained ROE deterioration. The Medical segment's persistent operating losses of 0.1 billion yen despite 7.4 times revenue growth suggests extended payback periods on development investments, and similar risks may exist in other growth initiatives.
[Industry Position] (Reference - Proprietary Analysis)
Profitability metrics show operating margin of 6.8% and net profit margin of 4.1% for FY2025, with operating margin contracting 0.2 percentage points YoY from 7.1% despite revenue growth of 6.7%. ROE of 5.2% declined from higher prior year levels, falling below mid-tier manufacturers in the precision machinery and fastener sectors. Historical company trend shows operating margin averaged 6.8% in FY2025, with revenue growth accelerating to 6.7% from more modest levels, and dividend payout ratio of 32% in FY2025 maintaining conservative levels consistent with a capital-intensive manufacturing business model.
Financial health indicators show equity ratio of 71.1%, exceeding typical manufacturing sector medians of 40-50%, indicating conservative capital structure with minimal leverage. Current ratio of 303% and quick ratio of 262% substantially exceed standard benchmarks of 150-200%, reflecting strong liquidity positioning. Debt-to-equity ratio of 0.07 ranks in the bottom quartile of leverage utilization, providing substantial debt capacity for strategic initiatives or economic downturns.
Efficiency metrics show asset turnover of 0.87 times declining from prior year levels, falling below typical manufacturing sector medians of 1.0-1.2 times, indicating either capital-intensive operations or recent investment not yet yielding full returns. The 31-day extension in cash conversion cycle to 135 days significantly exceeds efficient manufacturers' 60-90 day cycles, with particular weakness in inventory management at 112 days and receivables collection at 90 days.
Growth trajectory shows 6.7% revenue expansion in FY2025, accelerating from historical averages, though operating profit growth of 3.2% lagged revenue growth due to margin compression. Net income growth of 33.7% primarily reflects tax rate normalization rather than underlying earnings expansion, as ordinary income declined 4.6% YoY.
Note: Industry benchmarks represent reference information from proprietary analysis of publicly available financial data for comparative context. Individual company circumstances may drive legitimate deviations from median metrics.
Fastener segment dependency defines near-term earnings trajectory, with 73.9% revenue concentration and 66.2% profit contribution creating asymmetric exposure to this single business line. The segment's 10.2% revenue growth and 38.8% profit growth in FY2025 drove consolidated results as Machinery and Control System segments contracted, indicating cyclical demand divergence rather than broad-based strength. Sustainability of Fastener momentum, whether driven by market share gains, end-market expansion, or cyclical factors, determines whether FY2025 represents peak earnings or a foundation for continued growth. Management's full-year guidance implying 3.5% revenue growth and 10.7% operating income growth suggests confidence in sustained Fastener strength with margin expansion, though actual FY2025 results showed 90% achievement rates indicating execution challenges or conservative initial forecasting.
Working capital management has emerged as the critical constraint on cash generation and financial flexibility, with cash conversion cycle extending 31 days to 135 days and absorbing approximately 1.0 billion yen of operating cash flow. The simultaneous deterioration across inventory days (plus 15 days), receivables days (plus 6 days), and payables days (minus 10 days) suggests systemic working capital discipline erosion rather than isolated timing effects. Free cash flow compressed to 0.2 billion yen from 1.6 billion yen YoY despite 33.7% net income growth, limiting capacity for dividend increases, debt reduction, or accelerated investment without external financing. The company's 1.7 billion yen capital expenditure and M&A activity, combined with 0.8 billion yen dividend requirements, exceeded organic cash generation by 2.3 billion yen, necessitating 1.1 billion yen borrowing increase and 4.9 billion yen cash balance drawdown. Restoration of working capital efficiency to prior year levels would release approximately 1.0 billion yen cash and restore self-funding capacity, representing the most immediate opportunity for financial performance improvement.
Investment cycle implications center on returns from the 1.7 billion yen capex (119% of depreciation) and estimated 0.3-0.5 billion yen M&A activity driving goodwill and intangible asset increases. Asset turnover deteriorated to 0.87 times and ROA declined to 3.7% as the expanded asset base has not yet generated proportional earnings, typical of J-curve effects in growth investment but requiring monitoring for return realization. The Medical segment's persistent 0.1 billion yen operating loss despite 7.4 times revenue growth to 0.15 billion yen illustrates extended development timelines, while Machinery and Control System segment profit declines of 33.4% and 24.7% respectively raise questions about return erosion in mature businesses. Management's margin expansion guidance from 6.8% to 7.3% implies expected operating leverage from recent investments, with achievement depending on Fastener momentum continuation, industrial segment stabilization, and overhead absorption. The conservative 71.1% equity ratio and minimal 0.07 debt-to-equity provide financial flexibility to sustain investment through temporary performance volatility, though sustained suboptimal returns would pressure ROE and strategic credibility.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.